9 recruiting, 4 not yet recruiting, 2 active not recruiting, 2 completed. 8 Not applicable, 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 8 | Recruiting 6, Not yet recruiting 2 |
| Phase 1 | 2 | Active not recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Ulcerative Colitis (Disorder): new trials by email Literature Review of Ulcerative Colitis (Disorder) trials Research Report on Ulcerative Colitis (Disorder)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Objective Disease Control and Treatment Strategies in Ulcerative Colitis Routine Clinical Care - Ulcerative Colitis (Disorder) | Not yet recruiting | First Affiliated Hospital, Sun Yat-Sen University | 1000 | 2026-11-01 | 2026-10-16 | |
| Efficacy and Safety of Guselkumab in Patients With Moderate-to-Severe Ulcerative Colitis Guselkumab - Ulcerative Colitis (Disorder), Guselkumab | Recruiting | Second Affiliated Hospital of Wenzhou Medical University | 97 | 2026-07-31 | 2026-10-20 | |
| A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult BDHK-2009 Tablets, Placebo - Ulcerative Colitis (UC), Ulcerative Colitis (Disorder) | Phase 1 | Recruiting | Benethera (Shaoxing) Biotechnology Co., Ltd. | 68 | 2026-05-18 | 2026-06-08 |
| Sodium Butyrate and Kluyveromyces Marxianus Supplementation in Inflammatory Bowel Disease Butyrate - Ulcerative Colitis (Disorder) | Not applicable | Recruiting | University of Padova | 40 | 2026-05-01 | 2026-05-15 |
| Virtual Versus Dye-based Chromoendoscopy in Inflammatory Bowel Disease Surveillance Colonoscopy Virtual Chromoendoscopy, Dye-Based Chromoendoscopy - Inflammatory Bowel Disease (IBD), Ulcerative Colitis (Disorder) | Not applicable | Not yet recruiting | Region Stockholm | 480 | 2026-05-01 | 2026-03-20 |
| Mediterranean Diet and Time-Restricted Feeding in Ulcerative Colitis Remission Mediterranean Diet, Mediterranean Diet + Time-Restricted Feeding, Standard Dietary Advice - Ulcerative Colitis (Disorder), Inflammatory Bowel Disease (IBD) | Not applicable | Recruiting | Pontificia Universidad Catolica de Chile | 45 | 2026-04-10 | 2026-08-07 |
| Partial Enteral Nutrition to Prevent Weight Loss and Sarcopenia in IBD Patients at Nutritional Risk - SIMBA LH VIOLA Supplementation - Ulcerative Colitis (Disorder), Crohn Disease | Not applicable | Recruiting | Lionhealth Srl Società Benefit | 146 | 2026-03-09 | 2026-06-25 |
| Impact of Prior Identification and Education of Patients Requiring a Digestive Stoma for Fecal Diversion preoperative stoma identification and education - Colorectal Anastomosis, Endometrial | Not applicable | Not yet recruiting | Assistance Publique Hopitaux De Marseille | 100 | 2026-03-01 | 2025-11-18 |
| Effects of Pomegranate Juice on Ulcerative Colitis pomegranate juice -> habitual diet, habitual diet -> pomegranate juice - Ulcerative Colitis (Disorder) | Not applicable | Recruiting | University of California, Los Angeles | 30 | 2025-10-15 | 2025-12-09 |
| Efficacy and Safety of Etrasimod in Elderly Patients With Ulcerative Colitis Etrasimod administration - Ulcerative Colitis (Disorder) | Not applicable | Recruiting | Showa Inan General Hospital | 30 | 2025-10-01 | 2026-07-21 |
| Evaluation of a Multimodal Day Hospital for the Overall Management of Patients With Chronic Inflammatory Bowel Diseases (IBD) Inflammatory Bowel Disease (IBD), Crohn Disease | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 240 | 2025-09-01 | 2025-09-11 | |
| Study of Tissue Repair in Inflammatory Bowel Disease Exploiting Organoid Technology Colonoscopy - IBD inflamed tissue, Surgical resection - IBD inflamed mucous membrane, Colonoscopy - biopsies in healthy tissue - Crohn Disease, Inflammatory Bowel Diseases (IBD) | Not applicable | Recruiting | Assistance Publique Hopitaux De Marseille | 60 | 2025-07-24 | 2026-09-21 |
| The PODIUM Study - a Three-arm Comparison of Target Therapies After Anti-TNFα in Ulcerative Colitis Vedolizumab, Ustekinumab - Standard Dosage, JAK Inhibitor - Ulcerative Colitis (Disorder) | Recruiting | Humanitas Clinical and Research Center | 450 | 2023-08-01 | 2024-11-15 | |
| Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative Colitis Hydroxychloroquine, Mesalamine - Ulcerative Colitis (Disorder) | Phase 1 / Phase 2 | Active not recruiting | Icahn School of Medicine at Mount Sinai | 3 | 2022-06-10 | 2025-02-11 |
| A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease There is no intervention in this study - Gut Microbiome, Gastrointestinal Microbiome | Suspended | ProgenaBiome | 1000 | 2019-07-11 | 2026-09-21 | |
| LATA-IBD TRIAL a Controlled Feasibility Study for the Introduction of Transanal Minimally Invasive IPAA-Surgery. Evaluation of Operative Results and Bowel Function After Introducing Transanal IPAA-surgery to Replace Conventional Laparoscopic IPAA-surgery. Ulcerative Colitis (Disorder), Familial Adenomatous Polyposis (FAP) | Completed | Sahlgrenska University Hospital | 39 | 2018-04-18 | 2025-12-12 | |
| Development and External Validation of a Machine Learning Model for Pre-Endoscopic Prediction of Montreal Disease Extent (E1/E2/E3) in Ulcerative Colitis Using Symptoms, Signs, and Laboratory Tests: A Multicenter Retrospective Observational Study Ulcerative Colitis (Disorder) | Active not recruiting | Beijing University of Chinese Medicine | 1500 | 2015-11-20 | 2026-08-18 | |
| Incremental Value of Traditional Chinese Medicine Features in Two-Stage Pre-Endoscopic Prediction Ulcerative Colitis (Disorder), Crohn Disease (CD) | Completed | Beijing University of Chinese Medicine | 1500 | 2015-01-01 | 2026-08-25 |
Colitis, Ulcerative (18) · Crohn Disease (8) · Inflammatory Bowel Diseases (7) · Colorectal Neoplasms (3) · Adenomatous Polyposis Coli (2) · Acne Vulgaris (1) · Alzheimer Disease (1) · Amyotrophic Lateral Sclerosis (1) · Anxiety Disorders (1) · Arthritis, Rheumatoid (1) · Autism Spectrum Disorder (1) · Autistic Disorder (1) · Bipolar Disorder (1) · Bipolar and Related Disorders (1) · Celiac Disease (1)
Colitis (18) · Colonic Diseases (18) · Digestive System Diseases (18) · Gastroenteritis (18) · Gastrointestinal Diseases (18) · Intestinal Diseases (18) · Inflammatory Bowel Diseases (11) · Digestive System Neoplasms (5) · Intestinal Neoplasms (5) · Neoplasms by Site (5) · Gastrointestinal Neoplasms (4) · Neoplasms (4) · Adenoma (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3)
Butyrates (1) · Diet, Mediterranean (1) · Educational Status (1) · Hydroxychloroquine (1) · Janus Kinase Inhibitors (1) · Mesalamine (1) · guselkumab (1) · vedolizumab (1)
Assistance Publique Hopitaux De Marseille (2) · Beijing University of Chinese Medicine (2) · Assistance Publique - Hôpitaux de Paris (1) · Benethera (Shaoxing) Biotechnology Co., Ltd. (1) · First Affiliated Hospital, Sun Yat-Sen University (1) · Humanitas Clinical and Research Center (1) · Icahn School of Medicine at Mount Sinai (1) · Lionhealth Srl Società Benefit (1) · Pontificia Universidad Catolica de Chile (1) · ProgenaBiome (1) · Region Stockholm (1) · Sahlgrenska University Hospital (1) · Second Affiliated Hospital of Wenzhou Medical University (1) · Showa Inan General Hospital (1) · University of California, Los Angeles (1)
France (3) · Italy (3) · United States (3) · China (2) · Sweden (2) · Chile (1) · Japan (1)
Alessandro Armuzzi, MD - PhD (1) · Antonio Di Sabatino, MD - PhD (1) · Daniela Pugliese, MD - PhD (1) · Edoardo V Savarino (1) · Fabiana Castiglione, MD - PhD (1) · Hanna de la Croix, Associate professor (1) · Jinliang Chen (1) · Judy H Cho, MD (1) · Paul Mclellan, Doctor (1) · Sabine Hazan, MD (1) · Subra Kugathasan, MD (1) · Yi Jiang (1) · Zhaoping Li, MD, PhD (1)
PMID 28057360, PMID 28057361, PMID 33359090, PMID 34614172, PMID 35483736, PMID 36508681, PMID 36933563, PMID 37069321, PMID 38041850, PMID 39706209, PMID 40835043, PMID 41616901
2025 (1), T32DK007180 (1)